Shamburg News · 8-K filed Nov 13, 2026, 4:45 PM EST
Apnimed Non-Reliance on Q2 2026 Financial Statements Over SASS Gain Classification
APMD · Apnimed, Inc.
- Financial statements
- Other event
- Materiality: high
On November 13, 2026, the Audit Committee of Apnimed, Inc. concluded that its previously issued financial statements for the three and six months ended June 30, 2026 should no longer be relied upon. The $85.4 million gain on the April 6, 2026 disposition of its 50% interest in Shionogi-Apnimed Sleep Science, LLC was incorrectly classified in continuing operations rather than discontinued operations. The company plans to restate these periods in a Form 10-Q/A filing, which it intends to file on November 13, 2026.
Source: SEC EDGAR, Form 8-K, Item 4.02, accession 0001193125-26-460864.
Written from the filing by Shamburg Markets. Figures are as reported by the company.